Green Cross HealthNZSE:GXH +1.01%63 Median PS Value is NZ$1.14 as of Jul. 09, 2026, which is 100% below its 10-year median of 0.39. GuruFocus rates NZSE:GXH with a GF Score™ of 63/100 and a GF Value™ of NZ$1.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 262 Healthcare Providers & Services companies, Green Cross Health ranks worse than 92.37% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Green Cross Health's Median PS Value or its related term are showing as below:
NZSE:GXH'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22 Med: 0.39 Max: 1.75
Current: 1.75
During the past 13 years, the highest Price to Median PS Value of Green Cross Health was 1.75. The lowest was 0.22. And the median was 0.39.
NZSE:GXH's Price-to-Median-PS-Value is ranked worse than 92.37% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.705
vs NZSE:GXH: 1.75
Green Cross Health (NZSE:GXH) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Green Cross Health's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.00
/
1.14
=
1.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health Median PS Value Related Terms
Green Cross Health Median PS Value Historical Data
* Premium members only.
The historical data trend for Green Cross Health's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health Median PS Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Green Cross Health's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Cross Health Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Green Cross Health's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Green Cross Health's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.3015.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Green Cross Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$3.781.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health (NZSE:GXH) has a Median PS Value of NZ$1.14 as of Jul. 09, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Green Cross Health and its competitors. This is 192% above median its historical median of 0.39. Over the past decade, Green Cross Health's Median PS Value has ranged from 0.22 to 1.75. According to the industry distribution chart, Green Cross Health ranks #242 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 92.4%.
Is Green Cross Health's Median PS Value too high?
Green Cross Health's current Median PS Value of NZ$1.14 is 192% above median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 1.75. Based on the distribution chart, Green Cross Health ranks #242 out of 262 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Green Cross Health has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's Median PS Value compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Green Cross Health ranks #242 out of 262 companies for Median PS Value. This places Green Cross Health in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, Green Cross Health's own Median PS Value has ranged from 0.22 to 1.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Green Cross Health and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Cross Health's current Median PS Value is NZ$1.14, which is 192% above median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$2.00 — trading 85.2% above its estimated fair value. The current Median PS Value is NZ$1.14, which is 192% above median its 10-year median of 0.39. Green Cross Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current Median PS Value is NZ$1.14 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Cross Health (NZSE:GXH) Overvalued in 2026?
Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued.
The current stock price of NZ$2.00 is trading 85.2% above its estimated GF Value™ of NZ$1.08.
GuruFocus considers Green Cross Health to be Significantly Overvalued.
Key valuation signals for NZSE:GXH:
Median PS Value: NZ$1.14 (192% above median its 10-year median of 0.39)
GF Value™: NZ$1.08 vs. price of NZ$2.00 (85.2% above fair value)
No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
63GF Score
Get the complete analysis for NZSE:GXH
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:GXH has been successfully added to your 
